10 news items
SeaStar Medical Announces The Publication Of A Peer-Reviewed Article In 'Nature Scientific Reports' Describes The Mechanism Of Action Of The Co's Selective Cytopheretic Device In The Immunomodulation Of Excessive Inflammation
ICU
7 Jun 24
) 14:12747, investigated the SCD as an evolving approach to treating organ dysfunction arising from hyperinflammation and the cytokine storm by processing leukocytes in an extracorporeal circuit.
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical's Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
ICU
7 Jun 24
hyperinflammatory disease states," authored by Angela J. Westover, H. David Humes and Christopher J. Pino, (2024) 14:12747, investigated the SCD
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
ICU
28 Apr 24
, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
ICU
24 Apr 24
(GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation ("SeaStar" or the "Company
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
ICU
20 Apr 24
, April 20, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical
t8z9901d1h0 d4djcpxilrvwrm1xxf9nfw
ICU
16 Apr 24
(GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation ("SeaStar" or the "Company
adu40eyorcyju
ICU
12 Apr 24
, April 12, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical
1t2d r2fk2s9qrpx63ujkao3gs6jiaax7hwj6tksuwg5tl
ICU
8 Apr 24
(GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation ("SeaStar" or the "Company
25ddfpkwyrg7z5kppajeuqs6ewxs o7zwnyhdxsn6q1xdumbb4z
ICU
4 Apr 24
, April 4, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical
v5eq iemvuwmi2mvhuuhvz7lpbmw1thgdlhkpogls84k8m
ICU
28 Mar 24
, March 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical
- Prev
- 1
- Next